NCT04710082View on ClinicalTrials.gov

Outcomes of a New Trans-epithelial Photorefractive Keratectomy (Streamlight PRK) Compared to Conventional PRK Procedures

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Myopia ≤ -6 Diopters or Myopic Astigmatism ≤ -4 Diopters
Interventions
PROCEDURE

Photorefractive keratectomy (PRK)

Photorefractive keratectomy (PRK) is a surgical procedure used by ophthalmic surgeons to treat patients presented with refractive errors and involves corneal epithelial removal followed by application of excimer laser to correct different refractive errors including Myopia, Hyperopia and Astigmatism.

Trial Locations (1)

Unknown

TIBA eye center, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04710082 - Outcomes of a New Trans-epithelial Photorefractive Keratectomy (Streamlight PRK) Compared to Conventional PRK Procedures | Biotech Hunter | Biotech Hunter